Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$1.84 - $2.66 $29,977 - $43,336
16,292 New
16,292 $29,000
Q4 2022

Feb 06, 2023

BUY
$1.16 - $2.42 $18,898 - $39,426
16,292 New
16,292 $23,000
Q1 2022

Apr 28, 2022

SELL
$2.9 - $3.47 $70,446 - $84,293
-24,292 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$3.17 - $4.09 $77,005 - $99,354
24,292 New
24,292 $78,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $33.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Agate Pass Investment Management, LLC Portfolio

Follow Agate Pass Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agate Pass Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agate Pass Investment Management, LLC with notifications on news.